Relenza Rotadisk is a medicine containing the active ingredient(s) zanamivir. On this page you will find out more about Relenza Rotadisk, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: zanamivir
Information for medicine and pack size:
Relenza Rotadisk 5 mg powder for inhalation, 20 unit doses
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Treatment: Relenza (zanamivir) is indicated for the treatment of infections due to Influenza A and B viruses in adults and children aged 5 years and older. Treatment should commence as soon as possible but no later than forty-eight hours after the onset of the initial symptoms of infection (see Precautions). Prophylaxis: Vaccination remains the primary method of preventing and controlling influenza. Relenza is indicated for prophylaxis of Influenza A and B in adults and children (5 years and older) to reduce transmission among individuals in households with an infected person. Relenza is indicated for prophylaxis of influenza A and B during community outbreaks only in circumstances where such prophylaxis is justified (such as when vaccine that antigenically matches circulating influenza is not available or there is a pandemic). It is not recommended for routine prophylaxis against influenza infection.
Table of characteristics
|Visual appearance||Circular foil pack, approximately 4cm in diameter, with four regularly distributed blisters, each containing a white to off-white powder.|
|Route of administration||Inhalation|
20 (5 rotadisks x 4 blisters): Prescription Only Medicine, or Prescription Animal Remedy
20 (5 rotadisks x 4 blisters) with diskhaler: Prescription Only Medicine, or Prescription Animal Remedy
28 (7 rotodisks x 4 blisters) with diskhaler: Prescription Only Medicine, or Prescription Animal Remedy
4 (1 rotadisk x 4 blisters) (physician sample): Prescription Only Medicine, or Prescription Animal Remedy
4 (1 rotadisk x 4 blisters) with diskhaler (p.s.): Prescription Only Medicine, or Prescription Animal Remedy
60 (15 rotodisks x 4 blisters) with diskhaler: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||10 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.